Article Information
History
- April 29, 2020.
Article Versions
- Version 1 (April 24, 2020 - 19:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Amit Sud1,*,
- Michael Jones1,*,
- John Broggio2,*,
- Chey Loveday1,
- Bethany Torr1,
- Alice Garrett1,
- David L. Nicol3,
- Shaman Jhanji4,5,
- Stephen A. Boyce6,
- Phillip Ward4,
- Jonathan M. Handy4,
- Nadia Yousaf7,
- James Larkin8,9,
- Yae-Eun Suh10,
- Stephen Scott11,
- Paul D.P. Pharoah12,
- Charles Swanton13,14,
- Christopher Abbosh13,14,
- Matthew Williams15,16,
- Georgios Lyratzopoulos2,17,
- Richard Houlston1,18 and
- Clare Turnbull1,2,18,+
- 1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
- 2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
- 3Urology Unit, Royal Marsden NHS Foundation Trust, London, UK
- 4Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London, UK
- 5Division of Cancer Biology, Institute of Cancer Research, London, UK
- 6Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
- 7Lung Cancer Unit, Royal Marsden NHS Foundation Trust, London, UK
- 8Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, UK
- 9Division of Clinical Studies, Institute of Cancer Research, London, UK
- 10Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, London, UK
- 11RM Partners, West London Cancer Alliance, Royal Marsden NHS Foundation Trust, London, UK
- 12Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
- 13Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK
- 14Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK
- 15Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London, UK
- 16Computational Oncology Group, Imperial College London, London, UK
- 17Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, University College London, London, UK
- 18Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK
- ↵+Corresponding author: Prof. Clare Turnbull, clare.turnbull{at}icr.ac.uk
↵* these authors contributed equally to the work